Minnesota SF 1509: School buses external cameras grant program appropriation

Status: Referred to Transportation Finance and Policy (as of 2019-02-21)

State: Minnesota · Session: 2019-2020 · Bill: SF 1509

Subjects: Education and Education Department, Education-Pre-Kindergarten-12, Motor Vehicles, Public Safety and Public Safety Department, Transportation and Transportation Department

Sponsors: Anderson, B., Dibble, Frentz, Goggin, Rarick

Bill Text

1.1 A bill for an act
1.2 relating to human services; requiring medical assistance coverage of drugs covered
1.3 by a primary third-party payer; requiring coverage of in-network services by
1.4 medical assistance regardless of network or referral status for a primary third-party
1.5 payer; amending Minnesota Statutes 2024, sections 256B.0625, subdivisions 13,
1.6 25b; 256B.37, subdivision 5.
1.7 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.8 Section 1. Minnesota Statutes 2024, section 256B.0625, subdivision 13, is amended to
1.9 read:
1.10 Subd. 13.Drugs.(a) Medical assistance covers drugs, except for fertility drugs when
1.11 specifically used to enhance fertility, if prescribed by a licensed practitioner and dispensed
1.12 by a licensed pharmacist, by a physician enrolled in the medical assistance program as a
1.13 dispensing physician, or by a physician, a physician assistant, or an advanced practice
1.14 registered nurse employed by or under contract with a community health board as defined
1.15 in section 145A.02, subdivision 5, for the purposes of communicable disease control.
1.16 (b) The dispensed quantity of a prescription drug must not exceed a 34-day supply unless
1.17 authorized by the commissioner or as provided in paragraph (h) or the drug appears on the
1.18 90-day supply list published by the commissioner. The 90-day supply list shall be published
1.19 by the commissioner on the department's website. The commissioner may add to, delete
1.20 from, and otherwise modify the 90-day supply list after providing public notice and the
1.21 opportunity for a 15-day public comment period. The 90-day supply list may include
1.22 cost-effective generic drugs and shall not include controlled substances.
1.23 (c) For the purpose of this subdivision and subdivision 13d, an "active pharmaceutical
1.24 ingredient" is defined as a substance that is represented for use in a drug and when used in
1Section 1.
25-02755 as introduced02/06/25 REVISOR AGW/AC
SENATE
STATE OF MINNESOTA
S.F. No. 1509NINETY-FOURTH SESSION
(SENATE AUTHORS: BOLDON, Mann and Port)
OFFICIAL STATUSD-PGDATE
Introduction and first reading41302/17/2025
Referred to Health and Human Services
Author added Port675303/17/2026

2.1 the manufacturing, processing, or packaging of a drug becomes an active ingredient of the
2.2 drug product. An "excipient" is defined as an inert substance used as a diluent or vehicle
2.3 for a drug. The commissioner shall establish a list of active pharmaceutical ingredients and
2.4 excipients which are included in the medical assistance formulary. Medical assistance covers
2.5 selected active pharmaceutical ingredients and excipients used in compounded prescriptions
2.6 when the compounded combination is specifically approved by the commissioner or when
2.7 a commercially available product:
2.8 (1) is not a therapeutic option for the patient;
2.9 (2) does not exist in the same combination of active ingredients in the same strengths
2.10 as the compounded prescription; and
2.11 (3) cannot be used in place of the active pharmaceutical ingredient in the compounded
2.12 prescription.
2.13 (d) Medical assistance covers the following over-the-counter drugs when prescribed by
2.14 a licensed practitioner or by a licensed pharmacist who meets standards established by the
2.15 commissioner, in consultation with the board of pharmacy: antacids, acetaminophen, family
2.16 planning products, aspirin, insulin, products for the treatment of lice, vitamins for adults
2.17 with documented vitamin deficiencies, vitamins for children under the age of seven and
2.18 pregnant or nursing women, and any other over-the-counter drug identified by the
2.19 commissioner, in consultation with the Formulary Committee, as necessary, appropriate,
2.20 and cost-effective for the treatment of certain specified chronic diseases, conditions, or
2.21 disorders, and this determination shall not be subject to the requirements of chapter 14. A
2.22 pharmacist may prescribe over-the-counter medications as provided under this paragraph
2.23 for purposes of receiving reimbursement under Medicaid. When prescribing over-the-counter
2.24 drugs under this paragraph, licensed pharmacists must consult with the recipient to determine
2.25 necessity, provide drug counseling, review drug therapy for potential adverse interactions,
2.26 and make referrals as needed to other health care professionals.
2.27 (e) Effective January 1, 2006, medical assistance shall not cover drugs that are coverable
2.28 under Medicare Part D as defined in the Medicare Prescription Drug, Improvement, and
2.29 Modernization Act of 2003, Public Law 108-173, section 1860D-2(e), for individuals eligible
2.30 for drug coverage as defined in the Medicare Prescription Drug, Improvement, and
2.31 Modernization Act of 2003, Public Law 108-173, section 1860D-1(a)(3)(A). For these
2.32 individuals, medical assist

View Minnesota SF 1509 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.